Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Toshihide Kanamori"'
Autor:
Hideki Tomioka, Hironori Nakagami, Akiko Tenma, Yoshimi Saito, Toshihiro Kaga, Toshihide Kanamori, Nao Tamura, Kazunori Tomono, Yasufumi Kaneda, Ryuichi Morishita
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92597 (2014)
We developed a novel cationic antimicrobial peptide, AG30/5C, which demonstrates angiogenic properties similar to those of LL-37 or PR39. However, improvement of its stability and cost efficacy are required for clinical application. Therefore, we exa
Externí odkaz:
https://doaj.org/article/d5754996943347d7afc9ee5bc2b88ae7
Biocompatible polymer enhances thein vitro andin vivo transfection efficiency of HVJ envelope vector
Autor:
Seiji Yamamoto, Katsuto Tamai, Yasuhiko Tabata, Yasufumi Kaneda, Hidetoshi Mima, Ryuji Tomoshige, Susumu Ito, Toshihide Kanamori
Publikováno v:
The Journal of Gene Medicine. 7:888-897
Background Vector development is critical for the advancement of human gene therapy. However, the use of viral vectors raises many safety concerns and most non-viral methods are less efficient for gene transfer. One of the breakthroughs in vector tec
Autor:
Toshihiro Kaga, Yoshimi Saito, Nao Tamura, Yasufumi Kaneda, Toshihide Kanamori, Hideki Tomioka, Hironori Nakagami, Ryuichi Morishita, Kazunori Tomono, Akiko Tenma
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 3, p e92597 (2014)
PLoS ONE, Vol 9, Iss 3, p e92597 (2014)
We developed a novel cationic antimicrobial peptide, AG30/5C, which demonstrates angiogenic properties similar to those of LL-37 or PR39. However, improvement of its stability and cost efficacy are required for clinical application. Therefore, we exa
Autor:
Hideo Nariuchi, Yuji Yamanashi, Hidehiro Yamane, Toshihide Kanamori, Tadashi Yamamoto, David Baltimore, Toshiki Tamura
Publikováno v:
Genes & Development. 14:11-16
Antigenic stimulation of the B-cell receptor (BCR) is a central event in the immune response. In contrast, antigen bound to IgG negatively regulates signals from the BCR by cross-linking it to the inhibitory receptor FcγRIIB. Here we show that upon
Publikováno v:
BMC Medicine, Vol 5, Iss 1, p 28 (2007)
BMC Medicine
BMC Medicine
Background Inactivated HVJ (hemagglutinating virus of Japan; Sendai virus) particles (HVJ envelope vector; HVJ-E can incorporate and deliver plasmid DNA, siRNA, antibody and peptide and anti-cancer drugs to cells both in vitro and in vivo. We attempt